Cameron Brennan

Brigham and Women's Hospital — United States

Medicine · Health Sciences

92h-index70.9kcitations518works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(178), Circular RNAs in diseases(61), Nanoparticle-Based Drug Delivery(59), MicroRNA in disease regulation(58), Cancer Genomics and Diagnostics(57)

Publications512 total

INNV-33. Investigative needle core biopsies support multimodal deep-data generation in glioblastoma
Neuro-Oncology·2025
IMG-118. Glioblastoma distant recurrences preferentially occur along white matter tracts mapped using probabilistic diffusion tractography
Neuro-Oncology·2025Open Access
TMIC-37. A pathogenic subpopulation of human glioma associated macrophages linked to glioma progression
Neuro-Oncology·2025Open Access
Functional Magnetic Resonance Imaging–Guided Stereotactic Radiosurgery to Avoid Symptomatic Radionecrosis
International Journal of Radiation Oncology*Biology*Physics·2025
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses
Science Translational Medicine·2025· 7 cited
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors
Acta Neuropathologica·2025Open Access
Investigative needle core biopsies support multimodal deep-data generation in glioblastoma
Nature Communications·2025· 9 citedOpen Access
Abstract LB081: Carboxyamidotriazole orotate (CTO) with temozolomide (TMZ) for recurrent high-grade gliomas (rHGG) and in combination with TMZ/RT->TMZ in newly diagnosed glioblastoma (ndGBM): Long term follow-up of phase IB trial
Cancer Research·2025
Safety, tolerability, and clinical assessment of bemdaneprocel for Parkinson’s disease: Results through 24 months from a Phase 1 study
Parkinsonism & Related Disorders·2025
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
Nature·2025· 65 citedOpen Access
Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: Results Through 24 Months From a Phase 1 Study (S37.005)
Neurology·2025
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progression
2025· 1 citedOpen Access
Supplementary Data from Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in Cancer
2025Open Access
Data from Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in Cancer
2025Open Access
Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence
Neuron·2024· 22 citedOpen Access
CTIM-14. EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
Neuro-Oncology·2024Open Access
EPCO-32. PROSPECTIVE GERMLINE SEQUENCING OF PATIENTS WITH GLIOMAS, GLIONEURONAL OR NEURONAL TUMORS
Neuro-Oncology·2024Open Access
SURG-53. LONG TERM FOLLOW-UP OF RESECTION PLUS CESIUM-131 BRACHYTHERAPY FOR PREVIOUSLY IRRADIATED RECURRENT BRAIN METASTASES
Neuro-Oncology·2024Open Access
Modeling lung adenocarcinoma metastases using patient-derived organoids
Cell Reports Medicine·2024· 15 citedOpen Access
P12.09.A EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA
Neuro-Oncology·2024Open Access
page 1 of 26Next →

Frequent Co-authors

Lynda Chin(17), Ronald A. DePinho(12), Viviane Tabar(8), Ingo K. Mellinghoff(8), Philip H. Gutin(7), Jason T. Huse(7), Eric C. Holland(7), Alicia Pedraza(6), Carl Campos(6), Agnès Viale(5), Bin Feng(5), Tom Mikkelsen(4), Lisa M. DeAngelis(4), Marc Ladanyi(4), Timothy A. Chan(4), William C. Hahn(4), Keith L. Ligon(4), Christian Grommes(4), Marc K. Rosenblum(4), Ruprecht Wiedemeyer(4)